Circadian Clock Molecule REV-ERBα Regulates Lung Fibrotic Progression Through Collagen Stabilization
Overview
Authors
Affiliations
Molecular clock REV-ERBα is central to regulating lung injuries, and decreased REV-ERBα abundance mediates sensitivity to pro-fibrotic insults and exacerbates fibrotic progression. In this study, we determine the role of REV-ERBα in fibrogenesis induced by bleomycin and Influenza A virus (IAV). Bleomycin exposure decreases the abundance of REV-ERBα, and mice dosed with bleomycin at night display exacerbated lung fibrogenesis. Rev-erbα agonist (SR9009) treatment prevents bleomycin induced collagen overexpression in mice. Rev-erbα global heterozygous (Rev-erbα Het) mice infected with IAV showed augmented levels of collagens and lysyl oxidases compared with WT-infected mice. Furthermore, Rev-erbα agonist (GSK4112) prevents collagen and lysyl oxidase overexpression induced by TGFβ in human lung fibroblasts, whereas the Rev-erbα antagonist exacerbates it. Overall, these results indicate that loss of REV-ERBα exacerbates the fibrotic responses by promoting collagen and lysyl oxidase expression, whereas Rev-erbα agonist prevents it. This study provides the potential of Rev-erbα agonists in the treatment of pulmonary fibrosis.
Pan Z, Yao Y, Liu X, Wang Y, Zhang X, Zha S Cell Death Discov. 2024; 10(1):459.
PMID: 39472573 PMC: 11522549. DOI: 10.1038/s41420-024-02219-5.
Wang Q, Goracci C, Sundar I, Rahman I J Inflamm (Lond). 2024; 21(1):9.
PMID: 38509574 PMC: 10956237. DOI: 10.1186/s12950-024-00377-y.
Circadian Rhythms in Cardiovascular Metabolism.
Lal H, Verma S, Wang Y, Xie M, Young M Circ Res. 2024; 134(6):635-658.
PMID: 38484029 PMC: 10947116. DOI: 10.1161/CIRCRESAHA.123.323520.
Pulmonary Effects of Traumatic Brain Injury in Mice: A Gene Set Enrichment Analysis.
Chan W, Huang S, Chiu Y Int J Mol Sci. 2024; 25(5).
PMID: 38474264 PMC: 10931562. DOI: 10.3390/ijms25053018.
Abdulaal W, Asfour H, Helmi N, Al Sadoun H, Eldakhakhny B, Alhakamy N Front Pharmacol. 2024; 15:1333715.
PMID: 38449809 PMC: 10915016. DOI: 10.3389/fphar.2024.1333715.